Stifel analysts maintained a Buy rating and a $92.00 price target for Globus Medical (NYSE:GMED) stock following the company's announcement of acquiring Nevro Corp . (NYSE:NVRO) for an equity value of ...

LOS ANGELES, CA / ACCESS Newswire / February 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...

The class action lawsuit alleges Target leadership misled investors about the financial impact of boycotts in 2023.

The number of companies ending their diversity, equity, and inclusion programs continues to grow, with Google becoming one of ...

A number of prominent companies have scaled back or set aside the diversity, equity and inclusion initiatives that much of corporate America endorsed following the protests that accompanied the ...

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at ...

"It's a simple change. It gives law enforcement a tool to get guns out of unsafe hands before that trigger is pulled," ...

Target has been sued for allegedly concealing the risks of its diversity and social initiatives, leading to a backlash that ...

A new lawsuit claims Target misled shareholders about the risks of its diversity and inclusion initiatives, and now billions ...

Target Corporation, CEO Brian Cornell and current and former board members have been sued for defrauding stockholders about ...

On January 24, Target ended its DEI program, as well as a separate initiative to support Black-owned businesses that it had ...

American big box retailer Target Corp. (TGT) is facing a proposed class action lawsuit for defrauding investors about the ...